TY - JOUR T1 - Comorbidome and short-term prognosis in hospitalised COPD patients: the ESMI study JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/09031936.00008015 SP - ERJ-00080-2015 AU - Pere Almagro AU - Francisco Javier Cabrera AU - Jesus Diez-Manglano AU - Ramon Boixeda AU - Jesus Recio AU - Joan Mercade AU - Sergi Yun AU - Joan B. Soriano Y1 - 2015/04/21 UR - http://erj.ersjournals.com/content/early/2015/04/21/09031936.00008015.abstract N2 - Chronic obstructive pulmonary disease (COPD) patients have an increased prevalence of cardiovascular disease, cancer or psychiatric diseases, among many other comorbid conditions. This is explained in part by smoking history, along with genetic factors, ageing and the low grade inflammation characteristic of COPD [1, 2]. Although comorbidities may be present at the time of the initial diagnosis, their frequency increases with COPD progression, and are particularly common in patients with more advanced disease, especially in those hospitalised with acute exacerbations [3, 4]. These comorbidities complicate the management of COPD patients, lengthen hospital stay, cause physical functional dependency, increase number of readmissions, and are associated with decreased survival in the short, medium and long term [4–6]. A comorbidome is a useful representation of the prevalence and impact of comorbidities in hospitalised COPD patients http://ow.ly/KYzSF ER -